Alok is the Vice President of Life Sciences at Egnyte where he is responsible for building and executing the company's strategy for the life sciences market segment. Alok works across the organization to verticalize our marketing, sales, product, compliance, and account management practices for this domain. Before joining Egnyte, Alok was a Y Combinator-backed entrepreneur and started two vertical software-as-a-service companies. Prior to his career in software, Alok spent over 15 years as a scientist: he took part in postdoctoral work at Harvard University with George Whitesides, and has published papers in Nature and Nature Chemistry. Alok holds a PhD from Northwestern University and BS from Cornell University.
Health related information is increasingly being collected and stored digitally, with clinical trials as an increasing focal point in this new, digitalized landscape. Harnessing digital technologies create opportunities to drive valuable RWE generation and enriched data, increase efficiency, enhance trial planning, and maximize patient recruitment. How might sponsors best address challenges like data access, quality and creating/maintaining public trust in order to translate digital innovation into improved patient outcomes?